ADMA — ADMA BIOLOGICS INC

Ownership history in Squarepoint Ops LLC  ·  29 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q3)
Avg. % of fund
0.0%
First filed
2018 Q2
Last filed
2025 Q4
Quarters held
29
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 234,400 +127,919 +120.1% 0.00% $4.3M $18.24
2025 Q3 REDUCED 106,481 -132,519 -55.4% 0.00% $1.6M $14.66
2025 Q3 ADDED 239,000 +167,302 +233.3% 0.00% $3.5M $14.66
2025 Q2 REDUCED 71,698 -178,102 -71.3% 0.00% $1.3M $18.21
25 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%
← Back to Squarepoint Ops LLC Holdings